Skip to main content

January 2013

 

 

academics

 

Clinical research courses

Job as Site Leader - Haridwar Plant in Pfizer

Founded in 1849, Pfizer is the world's premier biopharmaceutical company taking new approaches to better health. We discover, develop, manufacture and deliver quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. We also partner with healthcare providers, governments and local communities around the world to expand access to our medicines and to provide better quality health care and health system support.

Opportunity for Product Manager - Immunology in Roche

At Roche, 80,000 people across 150 countries are pushing back the frontiers of healthcare. Working together, we’ve become one of the world’s leading research-focused healthcare groups. Our success is built on innovation, curiosity and diversity.

Walk in interview for the Post of Project Assistant Level - III in Indian institute of Chemical Biology

BUCCAL DRUG DELIVERY SYSTEM

About Author:
Prathipati padmaja
vathsalya college of pharmacy, JNTU
prathipatipadmaja@gmail.com

INTRODUCTION
Buccal drug delivery was introduced by Orabase1 in 1947, when gum tragacanth was mixed with dental adhesive powder to supply penicillin to the oral mucosa (Sudhakar et al., 2006). In recent years, delivery of therapeutic agents through various transmucosal routes has gained significant attention.
Buccal delivery of drugs provides an attractive alternative to the oral route of drug administration, particularly in overcoming deficiencies associated with the latter mode of dosing.  Buccal mucosa consist of stratified squamous epithelium supported by a connective tissue lamina propia (Squire and Wertz, 1996) was investigated as a site for drug delivery several decades ago and the interest in this area for the trasmucosal drug administration is still growing.

(adsbygoogle = window.adsbygoogle || []).push({});
Work as Deputy Manager in Biocon

Opportunity for Scientist E1 [Chemistry (Synthetic Organic)] in HLL Lifecare

HLL Lifecare Limited is a Mini Ratna Company of Govt. of India under the Ministry of Health & Family Welfare. HLL, a schedule B Public Sector Enterprise is today a multi product, multi unit organization addressing various public health challenges. The company with five manufacturing units and marketing offices throughout the country is engaged in the manufacturing and marketing of a wide range of contraceptives and healthcare products.

Opportunity for Brand Manager in Biocon

MAGNETIC MICROSPHERE

About Author:
Dipak Kumar Dash
M Pharm pharmaceutics
Production officer -Akorn india pvt ltd
dipak.dipak.dash@gmail.com

INTRODUCTION
Introduction In recent years, polymeric controlled drug delivery systems have evolved as one of the most attractive areas in drug delivery research. The drug release is controlled by properties of the polymer-drug system and also by other factors like pH, enzymes etc. Despite several advantages offered by the controlled drug release, one important problem pertinent to the entire field is that all the systems so far developed give release rates that are constant or decrease with time.Increased delivery on demand will be very beneficial in situations like, delivery of insulin for patients with diabetes mellitus, antiarrythmics in case of heart disorders and nitrates in case of angina pectoris. This increased delivery on demand can be achieved by using external feed back control systems such as magnetic control. The concept of magnetically controlled drug delivery for the first time was proposed be Tyle in 1988. A system has been developed to magnetize the carriers so that these particles can be retained on the target site by the application of an external magnetic field of appropriate strength. Magnetic fields are believed to be harmless to biological systems and adaptable to any part of the body.

ENHANCEMENT OF DISSOLUTION RATE OF CEFIXIME TRIHYDRATE BY USING VARIOUS SOLID DISPERSION TECHNIQUES

About Authors:
Narasimha Murthy Yedulapurapu*, Babu Rao. Chandu
Donbosco P.G. College of Pharmacy, 5th mile,
Pulladigunta, Kornepadu (V), vatticherukuru (M),
Guntur, Pin code: 522017, Andhra Pradesh.
*Murthyvedulapurapu@gmail.com

ABSTRACT:
Cefixime Trihydrate is an orally active third generation cephalosporin. It has plasma half-life of 3-4hrs; it is active against Gram+ve as well as Gram-ve bacteria. The present investigation involves the enhancement of dissolution rate of cefixime by using various solid dispersion techniques with a view to prolong the drug release in the gastrointestinal tract and consequently into the plasma. The solid dispersions were formulated by using the Croscarmelose sodium as a disintegrant. The solid dispersions were prepared by solvent evaporation, kneading, Physical mixing, Co-grinding techniques. In solvent evaporation technique, Dichloromethane is used as a solvent and in kneading technique water is used as solvent. The prepared solid dispersions were evaluated for in-vitro dissolution studies. Among the 5 formulations F5 sows the good results.

Work as Medical Writer in PPD Pharmaceuticals